CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer with Leptomeningeal Disease

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 18, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

EGFR Activating MutationLeptomeningeal MetastasisNon Small Cell Lung Cancer

Interventions

DIAGNOSTIC_TEST

Lumbar puncture and Phlebotomy

Sampling of cerebral spinal fluid and plasma.

Trial Locations (1)

RECRUITING

BC Cancer, Vancouver

All Listed Sponsors

lead

British Columbia Cancer Agency

OTHER